Aprea Therapeutics Inc (APRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,380 | -112,662 | -110,220 | -106,195 | -7,937 |
| Depreciation Amortization | 0 | 186 | 189 | 128 | 64 |
| Accounts payable and accrued liabilities | -17 | -859 | -565 | 2,289 | 215 |
| Other Working Capital | 1,370 | -1,759 | -92 | 2,552 | 430 |
| Other Operating Activity | 47 | 90,082 | 89,697 | 86,830 | 1,733 |
| Operating Cash Flow | $-2,979 | $-25,011 | $-20,991 | $-14,398 | $-5,495 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $0 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,789 | 683 | 584 | N/A | N/A |
| Other Financing Activity | -649 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $5,140 | $683 | $584 | $0 | $0 |
| Exchange Rate Effect | 48 | 39 | 443 | 384 | 71 |
| Beginning Cash Position | 28,787 | 53,076 | 53,076 | 53,076 | 53,076 |
| End Cash Position | 30,996 | 28,787 | 33,113 | 39,062 | 47,652 |
| Net Cash Flow | $2,209 | $-24,289 | $-19,964 | $-14,014 | $-5,424 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,979 | -25,011 | -20,991 | -14,398 | -5,495 |
| Free Cash Flow | -2,979 | -25,011 | -20,991 | -14,398 | -5,495 |